Spots Global Cancer Trial Database for adoptive cell transfer
Every month we try and update this database with for adoptive cell transfer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients With Synovial Sarcoma | NCT03250325 | Synovial Sarcom... | TBI-1301 Cyclophosphamid... | 18 Years - | Takara Bio Inc. | |
| Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma | NCT00512889 | Melanoma (Skin) | therapeutic aut... Use of an artif... GM-CSF Irradiation of ... | 18 Years - | Dana-Farber Cancer Institute | |
| Investigator Initiated Phase 1 Study of TBI-1301 | NCT02366546 | Solid Tumors | TBI-1301 Cyclophosphamid... Fludarabine | 20 Years - | Mie University | |
| Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases | NCT04812470 | Metastatic Uvea... Metastatic Cuta... | Autologous Tumo... Melphalan Interleukin-2 | 18 Years - | Vastra Gotaland Region | |
| Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour | NCT04107142 | Colorectal Canc... Triple Negative... Sarcoma Nasopharyngeal ... Prostate Cancer Gastric Cancer | Adoptive Cell T... | 18 Years - | CytoMed Therapeutics Pte Ltd | |
| Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma | NCT01005745 | Metastatic Mela... | Surgery Administration ... Adoptive Cell T... High Dose IL-2 | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Investigator Initiated Phase 1 Study of TBI-1301 | NCT02366546 | Solid Tumors | TBI-1301 Cyclophosphamid... Fludarabine | 20 Years - | Mie University | |
| Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients | NCT00160992 | Melanoma | Melan-A analog ... | 18 Years - | University of Lausanne Hospitals | |
| Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour | NCT04107142 | Colorectal Canc... Triple Negative... Sarcoma Nasopharyngeal ... Prostate Cancer Gastric Cancer | Adoptive Cell T... | 18 Years - | CytoMed Therapeutics Pte Ltd | |
| Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma | NCT00338377 | Melanoma | Dendritic Cell ... Cyclophosphamid... Fludarabine T-Cells Interleukin-2 Mesna Intrathecal T-C... Intrathecal Int... | 12 Years - | M.D. Anderson Cancer Center | |
| Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases | NCT04812470 | Metastatic Uvea... Metastatic Cuta... | Autologous Tumo... Melphalan Interleukin-2 | 18 Years - | Vastra Gotaland Region | |
| Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients With Synovial Sarcoma | NCT03250325 | Synovial Sarcom... | TBI-1301 Cyclophosphamid... | 18 Years - | Takara Bio Inc. | |
| Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma | NCT00512889 | Melanoma (Skin) | therapeutic aut... Use of an artif... GM-CSF Irradiation of ... | 18 Years - | Dana-Farber Cancer Institute | |
| T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma | NCT01946373 | Melanoma | Cyclophosphamid... Fludarabine T cells Interleukin-2 Dendritic cell ... | 18 Years - 74 Years | Karolinska University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
